Drug intelligence / Profile preview

CANNEFF VAG SUP

Development stage
Unknown
Lead developer
CB21 Pharma
Modality
Small Molecules, Device-based Delivery → Drug Delivery Systems
Administration
Vaginal
01

Overview

CANNEFF VAG SUP is a Class IIa medical device developed by CB21 Pharma for the treatment of various gynecological conditions. It is a vaginal suppository containing a combination of hyaluronic acid sodium salt and cannabidiol (CBD). The product is designed to alleviate symptoms of vaginal discomfort following treated inflammation or mycosis and to promote the healing of atrophic and dystrophic vaginal mucous membranes. These conditions often arise from childbirth, gynecological surgery, or as a result of chemotherapy, radiation therapy, or estrogen deficiency. The mechanism involves the local delivery of CBD and the hydrating properties of hyaluronic acid to restore the vaginal environment. It represents the first CBD-containing medical device to receive Class IIa certification in the European Union.

Brand names
CANNEFF VAG SUPCANNEFF SUP
Other names
CANNEFF SUP - Vaginal Suppositories

Beyond the preview

Go deeper on CANNEFF VAG SUP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CANNEFF VAG SUP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call